Antiviral Combination Therapy With Low-Dose Hepatitis B Immunoglobulin for the Prevention of Hepatitis B Virus Recurrence in Liver Transplant Recipients: A Single-Center Experience


AKÇAM A. T. , ULKU A., RENCÜZOĞULLARI A. , ERAY İ. C. , Okoh A., KURAN S. , ...Daha Fazla

TRANSPLANTATION PROCEEDINGS, cilt.47, ss.1445-1449, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

Objectives. This study presents the overall long-term hepatitis B virus (HBV) recurrence rate with possible associated factors after hepatitis B immunoglobulin (HBIG) was given in combination with 4 different antiviral (lamivudine, adefovir, entecavir, and tenofovir) drugs.